A meta-analysis of randomized, controlled trials in metastatic melanoma establishes progression-free survival as a surrogate for overall survival

被引：0
|
作者：
Flaherty, K. T. [1 ]
Lee, S. J. [2 ]
Dummer, R. [3 ]
Hauschild, A. [4 ]
Hennig, M. [5 ]
Long, G. V. [6 ,7 ]
Lorigan, P. [8 ]
Robert, C. [9 ]
Schadendorf, D. [10 ]
机构：
[1] Massachusetts Gen Hosp, Ctr Canc, Boston, MA USA
[2] Dana Farber Canc Inst, Boston, MA 02115 USA
[3] Univ Zurich Hosp, Dept Dermatol, CH-8091 Zurich, Switzerland
[4] Univ Kiel, Dept Dermatol, Kiel, Germany
[5] GlaxoSmithkline, Biostat & Epidemiol, Munich, Germany
[6] Univ Sydney, Melanoma Inst Australia, Sydney, NSW 2006, Australia
[7] Univ Sydney, Westmead Hosp, Sydney, NSW 2006, Australia
[8] Christies Hosp, Sch Oncol, Manchester, Lancs, England
[9] Inst Gustave Roussy, Dept Dermatol, Villejuif, France
[10] Univ Hosp Essen, Dept Dermatol, Essen, Germany
来源：
EUROPEAN JOURNAL OF CANCER | 2013年 / 49卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3702
引用
收藏
页码：S856 / S856
页数：1
相关论文
共 50 条
  • [1] META-ANALYSIS OF THE VALIDITY OF PROGRESSION-FREE SURVIVAL AS A SURROGATE ENDPOINT FOR OVERALL SURVIVAL IN METASTATIC COLORECTAL CANCER TRIALS
    Chirila, C.
    Odom, D. M.
    Devercelli, G.
    Khan, S.
    Sherif, B. N.
    Kaye, J. A.
    Molnar, I.
    Sherrill, B. H.
    ANNALS OF ONCOLOGY, 2010, 21 : 202 - 202
  • [2] PROGRESSION-FREE SURVIVAL (PFS) AS A SURROGATE ENDPOINT FOR OVERALL SURVIVAL (OS) IN PREVIOUSLY UNTREATED ADVANCED MELANOMA: A CORRELATION META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS (RCTS)
    Leung, L.
    Chou, E.
    Kurt, M.
    Moshyk, A.
    Hamilton, M.
    Pourrahmat, M. M.
    Kanters, S.
    VALUE IN HEALTH, 2022, 25 (01) : S22 - S22
  • [3] Progression-Free Survival as a Surrogate for Overall Survival in Advanced/Recurrent Gastric Cancer Trials: A Meta-Analysis
    Paoletti, Xavier
    Oba, Koji
    Bang, Yung-Jue
    Bleiberg, Harry
    Boku, Narikazu
    Bouche, Olivier
    Catalano, Paul
    Fuse, Nozomu
    Michiels, Stefan
    Moehler, Markus
    Morita, Satoshi
    Ohashi, Yasuo
    Ohtsu, Atsushi
    Roth, Arnaud
    Rougier, Philippe
    Sakamoto, Junichi
    Sargent, Daniel
    Sasako, Mitsuru
    Shitara, Kohei
    Thuss-Patience, Peter
    Van Cutsem, Eric
    Burzykowski, Tomasz
    Buyse, Marc
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2013, 105 (21): : 1667 - 1670
  • [4] Progression-free survival as a surrogate endpoint for overall survival in modern ovarian cancer trials: a meta-analysis
    Sjoquist, Katrin M.
    Lord, Sarah J.
    Friedlander, Michael L.
    Simes, Robert John
    Marschner, Ian C.
    Lee, Chee Khoon
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2018, 10 : 1 - 16
  • [5] Surrogate endpoints for overall survival in metastatic melanoma: a meta-analysis of randomised controlled trials
    Flaherty, Keith T.
    Hennig, Michael
    Lee, Sandra J.
    Ascierto, Paolo A.
    Dummer, Reinhard
    Eggermont, Alexander M. M.
    Hauschild, Axel
    Kefford, Richard
    Kirkwood, John M.
    Long, Georgina V.
    Lorigan, Paul
    Mackensen, Andreas
    McArthur, Grant
    O'Day, Steven
    Patel, Poulam M.
    Robert, Caroline
    Schadendorf, Dirk
    LANCET ONCOLOGY, 2014, 15 (03): : 297 - 304
  • [6] INVESTIGATING PROGRESSION-FREE SURVIVAL AS A POTENTIAL SURROGATE ENDPOINT FOR OVERALL SURVIVAL IN FIRST-LINE TREATMENT FOR GLIOBLASTOMA MULTIFORME: A META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS
    Fu, A.
    Fazeli, M. S.
    Kanters, S.
    Siliman, G.
    Ma, Chaudhary
    Gogate, A.
    Kurt, M.
    VALUE IN HEALTH, 2020, 23 : S4 - S4
  • [7] Interpretation of meta-analysis evaluating progression-free survival as a surrogate endpoint for overall survival in glioblastoma
    Han, Kelong
    Ren, Melanie
    Wick, Wolfgang
    Abrey, Lauren
    Das, Asha
    Jin, Jin
    Reardon, David A.
    NEURO-ONCOLOGY, 2015, 17 (05) : 764 - 765
  • [8] PROGRESSION-FREE SURVIVAL AS A SURROGATE FOR OVERALL SURVIVAL IN METASTATIC BREAST CANCER
    Beauchemin, C.
    Cooper, D.
    Lapierre, M. E.
    Yelle, L.
    Lachaine, J.
    VALUE IN HEALTH, 2012, 15 (07) : A414 - A414
  • [9] PROGRESSION-FREE SURVIVAL AS A SURROGATE FOR OVERALL SURVIVAL IN METASTATIC BREAST CANCER
    Beauchemin, C.
    Cooper, D.
    Lapierre, M.
    Yelle, L.
    Lachaine, J.
    ANNALS OF ONCOLOGY, 2012, 23 : 119 - 120
  • [10] Meta-analysis of the association between progression-free survival and overall survival in metastatic colorectal cancer
    Chirila, Costel
    Odom, Dawn
    Devercelli, Giovanna
    Khan, Shahnaz
    Sherif, Bintu N.
    Kaye, James A.
    Molnar, Istvan
    Sherrill, Beth
    INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2012, 27 (05) : 623 - 634
12345